← Back to headlines
Deramiocel Outlook Boosts Capricor Therapeutics (CAPR) as Small-Cap Stock
The positive outlook for Deramiocel is strengthening Capricor Therapeutics, Inc. (CAPR) as a small-cap stock. This development positions CAPR as a potential buy.
6 Jun, 00:12 — 6 Jun, 00:12
Sources
Showing 1 of 1 sources
